EU MDR RESOURCE

EU MDR Regulatory Consulting

EU MDR strategy and regulatory support for medical device companies pursuing or maintaining CE marking under Regulation (EU) 2017/745.

EU MDR raised the bar for market access

Regulation (EU) 2017/745 increased expectations for technical documentation, clinical evidence, post-market surveillance, and notified body scrutiny. Companies entering or maintaining the EU market need a clear, resourced plan.

Common EU MDR support areas

  • EU MDR classification and CE marking strategy
  • Technical documentation gap assessment and planning
  • General Safety and Performance Requirements (GSPR) mapping
  • EU market entry sequencing alongside FDA strategy
  • Post-market surveillance and lifecycle planning
  • Notified body interaction preparation

US and EU strategy, planned together

EZ Regulatory helps MedTech teams sequence FDA and EU MDR work so evidence, documentation, and timelines support both markets instead of duplicating effort.

Common questions

What is EU MDR?

EU MDR is Regulation (EU) 2017/745, the European Union regulation governing medical devices. It defines requirements for CE marking, technical documentation, clinical evaluation, and post-market obligations for devices sold in the EU.

Do US companies need separate EU MDR work after FDA clearance?

Yes. FDA clearance does not grant EU market access. EU MDR requires its own conformity assessment, technical documentation, and in most cases a notified body review before CE marking.